Cargando…

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

INTRODUCTION: The constantly mutating SARS-CoV-2 has been infected an increasing number of people, hence the safe and efficacious treatment are urgently needed to combat the COVID-19 pandemic. Currently, neutralizing antibodies (Nabs), targeting the receptor-binding domain (RBD) of the SARS-CoV-2 sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Kaikai, Liu, Bin, Yu, Haotian, Sun, Chengbiao, Wang, Xuefeng, Li, Guorui, Dong, Mingxin, Wang, Yan, Zhang, Jianxu, Xu, Na, Liu, Wensen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189128/ https://www.ncbi.nlm.nih.gov/pubmed/37207187 http://dx.doi.org/10.3389/fcimb.2023.1155293

Ejemplares similares

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022)

Recombinant Ricin Toxin Binding Subunit B (RTB) Stimulates Production of TNF-α by Mouse Macrophages Through Activation of TLR4 Signaling Pathway
por: Xu, Na, et al.
Publicado: (2020)

CircEpc1 Promotes Ricin Toxin-Induced Inflammation via Activation of NF-κB and MAPK Signaling Pathways by Sponging miR-5114
por: Dong, Mingxin, et al.
Publicado: (2021)

Enhancing the antivirus activity of chimeric canine interferon with ricin subunit B by using nanoparticle formulations
por: Sun, Chengbiao, et al.
Publicado: (2020)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Development of a Single-Chain Variable Fragment of CR3022 for a Plasmonic-Based Biosensor Targeting the SARS-CoV-2 Spike Protein
por: Tohari, Taufik Ramdani, et al.
Publicado: (2022)

An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
por: Yuan, Mengqi, et al.
Publicado: (2023)

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
por: Atyeo, Caroline, et al.
Publicado: (2021)

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
por: Yan, Hongxia, et al.
Publicado: (2022)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
por: Choi, Ju-yeon, et al.
Publicado: (2022)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
por: Wang, Rong, et al.
Publicado: (2019)

The Shigella Type III Secretion Effector IpaH4.5 Targets NLRP3 to Activate Inflammasome Signaling
por: Wang, Xiaolin, et al.
Publicado: (2020)

Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort
por: Huang, Jianliang, et al.
Publicado: (2023)

Enteropathogenic Escherichia coli Mediates CoCrMo Particle-Induced Peri-Implant Osteolysis by Increasing Peripheral 5-HT
por: Xue, Kaiwen, et al.
Publicado: (2022)

Structure Based Affinity Maturation and Characterizing of SARS-CoV Antibody CR3022 against SARS-CoV-2 by Computational and Experimental Approaches
por: Yu, Wei, et al.
Publicado: (2022)

GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice
por: Chang, Ying, et al.
Publicado: (2019)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Understanding clinical characteristics influencing adverse outcomes of Omicron infection: a retrospective study with propensity score matching from a Fangcang hospital
por: Geng, Yanxia, et al.
Publicado: (2023)

The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China
por: Li, Hongru, et al.
Publicado: (2022)

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
por: Wang, Yingdan, et al.
Publicado: (2022)

Ocular Effects of Glycyrrhizin at Acidic and Neutral pH
por: Somayajulu, Mallika, et al.
Publicado: (2022)

Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot
por: Sherchand, Shardulendra Prasad, et al.
Publicado: (2022)

Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance
por: KS, Sandhya, et al.
Publicado: (2023)

Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time
por: Wang, Lijie, et al.
Publicado: (2022)

Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant
por: Wu, Jiajun, et al.
Publicado: (2022)

Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
por: Guo, Wenjing, et al.
Publicado: (2023)

Porphyromonas gingivalis Induces Increases in Branched-Chain Amino Acid Levels and Exacerbates Liver Injury Through livh/livk
por: Wu, Leng, et al.
Publicado: (2022)

Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020
por: Yuan, Yajie, et al.
Publicado: (2021)

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
por: Schulz, Sebastian R., et al.
Publicado: (2022)

Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2
por: Li, Jianguo, et al.
Publicado: (2022)

The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
por: Shen, Min, et al.
Publicado: (2023)

The role of short-chain fatty acids produced by gut microbiota in the regulation of pre-eclampsia onset
por: Cui, Jinghan, et al.
Publicado: (2023)

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis
por: Zhang, Yong, et al.
Publicado: (2023)

Effects of Short-Chain Fatty Acid Modulation on Potentially Diarrhea-Causing Pathogens in Yaks Through Metagenomic Sequencing
por: Li, Kun, et al.
Publicado: (2022)

Can the nucleic acid Ct value of discharged patients infected with SARS-CoV-2 Omicron variant be 35?——A retrospective study on fluctuation of nucleic acid Ct values in SNIEC mobile cabin hospital
por: Zhuang, Xu, et al.
Publicado: (2022)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody
por: Nguyen, Hung, et al.
Publicado: (2021)

Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients
por: Liu, Yanfeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_87nlvg15c57nuv22llc14crrmb